Tamsulosin

CAS Number: 106133-20-4

Molecular Formula: C20H28N2O5S

About Tamsulosin

The global Tamsulosin market, valued at approximately USD 2.1 billion in 2024, is witnessing a robust growth trajectory driven by the increasing prevalence of benign prostatic hyperplasia (BPH) among an ageing global population, with over 50% of men over 60 experiencing symptoms. Market dynamics are currently defined b...

Synonyms

5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
Flomax
LY 253352
LY-253352
tamsulosin

View all

Tamsulosin Specifications

CAS Number

106133-20-4

Molecular Formula

C20H28N2O5S

IUPAC Name

5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide

Canonical SMILES

CCOc1ccccc1OCCNC(Cc1ccc(c(c1)S(=O)(=O)N)OC)C

InChI Key

DRHKJLXJIQTDTD-OAHLLOKOSA-N

HSN No

30049099

CAS Number

106133-20-4

Molecular Formula

C20H28N2O5S

IUPAC Name

5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide

Canonical SMILES

CCOc1ccccc1OCCNC(Cc1ccc(c(c1)S(=O)(=O)N)OC)C

InChI Key

DRHKJLXJIQTDTD-OAHLLOKOSA-N

HSN No

30049099

Precautionary Statement Codes

P261, P264, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501

Hazard Classes and Categories

Acute Tox. 4 (100%) Skin Irrit. 2 (100%)

Pharmaceutical Active Ingredient

A selective alpha-1 adrenergic receptor antagonist primarily used in the treatment of symptomatic benign prostatic hyperplasia (BPH) to improve urine flow by relaxing smooth muscles in the prostate and bladder neck

Urological Therapeutic Agent

A prescription medication utilized to alleviate lower urinary tract symptoms such as frequency, urgency, and hesitant urination in male patients

Medical Research Compound

A specific adrenoceptor blocker studied in clinical trials for its efficacy in treating chronic prostatitis and facilitating the passage of distal ureteral stones.